The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse
Obul Reddy Bandapalli(European Molecular Biology Organization), S. Schuessele(European Molecular Biology Organization), Joachim B. Kunz(University Hospital Heidelberg), Tobias Rausch(European Molecular Biology Laboratory), Adrian M. Stütz(European Molecular Biology Laboratory), Noam Tal-Perry(Tel Aviv University), Ifat Geron(Sheba Medical Center), Nava Gershman(Tel Aviv University), Shai Izraeli(Tel Aviv University), June Eilers(European Molecular Biology Organization), Nina Vaezipour(European Molecular Biology Organization), Renate Kirschner‐Schwabe(Charité - Universitätsmedizin Berlin), Jana Hof(Heidelberg University), A von Stackelberg(Charité - Universitätsmedizin Berlin), Martin Schrappe(University Hospital Schleswig-Holstein), M. Stanulla(Medizinische Hochschule Hannover), M Zimmermann(Medizinische Hochschule Hannover), Rolf Koehler(Heidelberg University), S. Avigad(Schneider Children's Medical Center), Rupert Handgretinger(University Children's Hospital Tübingen), Viktoras Frismantas(University Children's Hospital Zurich), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Beat Bornhäuser(University Children's Hospital Zurich), Jan O. Korbel(European Molecular Biology Laboratory), Martina U. Muckenthaler(Heidelberg University), A. E. Kulozik(European Molecular Biology Organization)
Cited by 122Open Access
Abstract
WBC: white blood cell; *Fisher's exact test; **c 2 test; ***Pro/Pre (cyCD3 + , CD7 + / cyCD3 + , CD2 + and/or CD5 + and/or CD8 + ), cortical (CD1a + ), mature (CD1a -, sCD3 + ).
Related Papers
Somatically acquired <i>JAK1</i> mutations in adult acute lymphoblastic leukemia
Elisabetta Flex, Valentina Petrangeli, Lorenzo Stella et al.|The Journal of Experimental Medicine|2008|326